Search Saint Luke's

Colorectal Cancer

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

An elementary school music teacher and jazz musician, 54-year-old Lisa was initially diagnosed with high blood pressure—the number one killer of women—in her early 30s. It is often called “the silent killer” because most who have it don’t experience any symptoms. Lisa was on blood pressure medication but had stopped taking it because she experienced side effects. She put off seeing her doctor about it for several months.

Ramon Grado doesn’t remember driving home and then sprawling on the living room floor on Jan. 13, 2013. Patty, his wife of 33 years, found him there an hour later, awake and complaining about his headache.

Saint Luke’s Health System Antimicrobial and Diagnostic Advisement Program (ADAP) aims to promote the judicious use of antimicrobials, suppress antimicrobial resistance, decrease the negative effects of unnecessary antimicrobial use, and improve outcomes for the patients we serve.

Pancreatic Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Anderson County Hospital is pleased to announce the continuation of a nursing scholarship program

CV Surgery
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients with Aortic Regurgitation

Mitral Regurgitation
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population

Heart Failure

A Phase 1/2, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous ATR 1072 for the Treatment of PRKAG2 Syndrome

As President and CEO of an aviation company headquartered in New York City, Ron Ricciardi is constantly on the go. The Kansas City resident splits his time between his home in the Midwest and his office on the East Coast, commuting one direction or the other every week by plane.